Bir sonraki

Otomatik oynatma

RADIANT-3 Trial: Everolimus in Pancreatic Neuroendocrine Tumors

0 Görünümler • 07/08/23
Pay
gömmek
administrator
administrator
Aboneler
0

Jonathan Strosberg, MD, Diane Reidy-Lagunes, MD, MS, and Rodney F. Pommier, MD, discuss results from the phase III RADIANT-3 trial that explored everolimus in patients with pancreatic neuroendocrine tumors.

For more from this discussion, visit http://www.onclive.com/peer-ex....change/pancreatic-ne

Daha fazla göster
0 Yorumlar sort Göre sırala
Facebook Yorumları

Bir sonraki

Otomatik oynatma